More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Background Colonoscopy to detect colorectal cancer (CRC) is recommended starting at age 50 years; however, CRC rates are increasing in the prescreening population. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has been proven effective in select patients with perito...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2019-03, Vol.26 (3), p.845-851
Hauptverfasser: Solomon, Daniel, DeNicola, Natasha L., Feferman, Yael, Bekhor, Eliahu, Reppucci, Marina L., Feingold, Daniela, Aycart, Samantha N., Magge, Deepa R., Golas, Benjamin J., Labow, Daniel M., Sarpel, Umut
Format: Artikel
Sprache:eng
Schlagworte:
Age composition
Chemotherapy
Colon
Colorectal cancer
Colorectal carcinoma
Diagnosis
Gastric cancer
Gastrointestinal Oncology
Medicine
Medicine & Public Health
Metastases
Metastasis
Morbidity
Oncology
Peritoneum
Surgery
Surgical Oncology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Colonoscopy to detect colorectal cancer (CRC) is recommended starting at age 50 years; however, CRC rates are increasing in the prescreening population. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has been proven effective in select patients with peritoneal carcinomatosis (PC) from CRC, although it has not been evaluated specifically in patients
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-018-07087-9